CLINICAL TRIALS AND OBSERVATIONS Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
نویسندگان
چکیده
1Department of Hematology, Hospital del Mar, Barcelona, Spain; 2Department of Hemotherapy and Hemostasis, Hospital Clínic, Barcelona, Spain; 3Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 4Department of Hematology and Oncology, Hospital Clínico, Valencia, Spain; 5Department of Hematology, Hospital Morales Messeguer, Murcia, Spain; 6Department of Hematology, Hospital Príncipe de Asturias, Alcalá de Henares, Spain; and 7Department of Pathology, Hospital del Mar, Barcelona, Spain
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria
A definition of response by cytoreductive therapy in essential thrombocythemia was recently provided by the European LeukemiaNet (ELN). Complete, partial, or no clinicohematologic responses were defined on the bases of platelet count, disease-related symptoms, spleen size, and white blood cell count. To provide estimates and clinical correlation of responses according to these criteria, we retr...
متن کاملCLINICAL TRIALS AND OBSERVATIONS European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor
The majority of patients with chronic myeloid leukemia in chronic phase gain substantial benefit from imatinib but some fail to respond or lose their initial response. In 2006, the European LeukemiaNet published recommendations designed to help identify patients responding poorly to imatinib. Patients were evaluated at 3, 6, 12, and 18 months and some were classified as “failure” or “suboptimal...
متن کاملI-12: Objective Embryo Assessment Utility of Time-Lapse
Background Traditionally, embryo incubation and assessment daily has been under a light microscope, these observations are inevitably restricted to specific times and considering that the development of the embryo is a dynamic process, several critical stages in between observations may go unnoticed. For this reason, the new technologies, time lapse monitoring, have focused on the research for ...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
Sixty-four patients < 20 years of age, investigated for a suspicion of Philadelphianegative myeloproliferative disease (MPD), were retrospectively evaluated to characterize the different forms and to examine the treatments used and longterm outcome. JAK2 mutations, endogenous erythroid colony growth, and clonality were investigated in 51 children. Mutations of thrombopoietin, the thrombopoietin...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
1Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Service d’Hématologie Clinique and Paris 13 University, Bobigny; 2Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Unité de Biologie Cellulaire, Paris; 3Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, DBIM, Paris; 4CHU Dupuytren, Service d’Hematologie, Limoges; 5CHRU de Lille, Hopital Huriez, Service des Maladies d...
متن کامل